This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Healthcare Realty (HR) Q3 FFO Meet Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered FFO and revenue surprises of 0.00% and 1.80%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Realty (HR) Matches Q2 Earnings Estimates
by Zacks Equity Research
Healthcare Realty (HR) delivered earnings and revenue surprises of 0.00% and -0.71%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Rising Healthcare Spending Aid HCP This Earnings Season?
by Zacks Equity Research
HCP Q2 results likely to reflect benefit from shedding of Brookdale assets. However, rising interest rates remains a concern.
Healthcare Realty (HR) Calls to Redeem Senior Notes Due 2021
by Zacks Equity Research
Healthcare Realty Trust (HR) to pay $113.4 million for early redemption of $100 million of the $400 million senior notes due in 2021.
Healthcare Realty (HR) to Buy Medical Buildings in Atlanta
by Zacks Equity Research
Healthcare Realty Trust (HR) to raise funds through public offering primarily to pursue acquisitions in Atlanta.
Healthcare Realty Trust (HR) Enters Overbought Territory
by Zacks Equity Research
Healthcare Realty Trust Incorporated (HR) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Healthcare Realty's (HR) Q4 FFO Beats, Revenues Up Y/Y
by Zacks Equity Research
Healthcare Realty Trust Inc.'s (HR) fourth-quarter 2016 normalized FFO per share of 41 cents came a penny above the Zacks Consensus Estimate.